To view the PDF file, sign up for a MySharenet subscription.

ADCOCK INGRAM HOLDINGS LIMITED - Acquisition of certain assets of Cosme Farma Laboratories Limited (India) - Fulfillment of conditions precedent

Release Date: 18/01/2013 07:05
Code(s): AIP     PDF:  
Wrap Text
Acquisition of certain assets of Cosme Farma Laboratories Limited (India) - Fulfillment of conditions precedent

Adcock Ingram Holdings Limited
(Registration number 2007/016236/06)
(Incorporated in the Republic of South Africa)
Share code: AIP
ISIN: ZAE000123436
("Adcock Ingram")


ACQUISITION OF CERTAIN ASSETS OF COSME FARMA LABORATORIES LIMITED (INDIA) - FULFILLMENT OF
CONDITIONS PRECEDENT


Shareholders are referred to the announcements released by Adcock Ingram on 10 July 2012 and 1 November
2012 relating to the acquisition of certain intangible assets of Cosme Farma Laboratories Limited, a pan-Indian
pharmaceutical company based in Goa, India (the “Transaction”).

Shareholders are advised that all conditions precedent to the Transaction have been met, or where
appropriate, waived by Adcock Ingram. The effective date of the Transaction is on 17 January 2013.

Additionally we draw shareholders’ attention to the following issues, which are disclosed on a voluntary basis:

1. The purchase price, as previously disclosed, of ZAR708 million has increased by ZAR37 million to ZAR745
   million. This increase is as a result of a 5.3% decrease in the exchange rate of the South Africa Rand against
   the Indian Rupee between 10 July 2012 and 21 December 2012, the latter date being the date of
   conversion of South African Rands to Indian Rupee;

2. The stamp duty, as previously disclosed, of INR240 million or ZAR35 million has reduced by approximately
   INR185 million or ZAR26 million to INR55 million or ZAR9 million;

3. An annual amortisation charge of approximately INR292 million or ZAR45 million has been calculated for
   inclusion in the pro forma Statement of Comprehensive Income. This charge together with the resultant
   tax effects does not have a material effect on the previously disclosed pro forma financial effects relating
   to the Transaction; and

4. The above amounts are based on a ZAR/INR exchange rate of 0.1474 as at 9 July 2012 and 0.1553 as at 21
   December 2012, the latter being the date of conversion of South African Rands to Indian Rupee.

Midrand
18 January 2013

Sponsor
Deutsche Securities (SA) Proprietary Limited

Date: 18/01/2013 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story